» Articles » PMID: 23894545

Characterization of a Surface Glycoprotein from Echinococcus Multilocularis and Its Mucosal Vaccine Potential in Dogs

Overview
Journal PLoS One
Date 2013 Jul 30
PMID 23894545
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Alveolar echinococcosis is a refractory disease caused by the metacestode stage of Echinococcus multilocularis. The life cycle of this parasite is maintained primarily between foxes and many species of rodents; thus, dogs are thought to be a minor definitive host except in some endemic areas. However, dogs are highly susceptible to E. multilocularis infection. Because of the close contact between dogs and humans, infection of dogs with this parasite can be an important risk to human health. Therefore, new measures and tools to control and prevent parasite transmission required. Using 2-dimensional electrophoresis followed by western blot (2D-WB) analysis, a large glycoprotein component of protoscoleces was identified based on reactivity to intestinal IgA in dogs experimentally infected with E. multilocularis. This component, designated SRf1, was purified by gel filtration using a Superose 6 column. Glycosylation analysis and immunostaining revealed that SRf1 could be distinguished from Em2, a major mucin-type antigen of E. multilocularis. Dogs (n=6) were immunized intranasally with 500 µg of SRf1 with cholera toxin subunit B by using a spray syringe, and a booster was given orally using an enteric capsule containing 15 mg of the same antigen. As a result, dogs immunized with this antigen showed an 87.6% reduction in worm numbers compared to control dogs (n=5) who received only PBS administration. A weak serum antibody response was observed in SRf1-immunized dogs, but there was no correlation between antibody response and worm number. We demonstrated for the first time that mucosal immunization using SRf1, a glycoprotein component newly isolated from E. multilocularis protoscoleces, induced a protection response to E. multilocularis infection in dogs. Thus, our data indicated that mucosal immunization using surface antigens will be an important tool to facilitate the development of practical vaccines for definitive hosts.

Citing Articles

Echinococcus granulosus sensu lato control measures: a specific focus on vaccines for both definitive and intermediate hosts.

Borhani M, Fathi S, Harandi M, Casulli A, Ding J, Liu M Parasit Vectors. 2024; 17(1):533.

PMID: 39716337 PMC: 11665232. DOI: 10.1186/s13071-024-06581-2.


Current status and future prospects of vaccine candidates: A systematic review.

Hataminejad M, Anvari D, Khaleghi N, Nayeri T, Shirazinia R, Shariatzadeh S Vet Anim Sci. 2024; 24:100345.

PMID: 38516388 PMC: 10950815. DOI: 10.1016/j.vas.2024.100345.


Immunoprotection of recombinant Eg.myophilin against infection in sheep.

Zhu M, Gao F, Li Z, Wang X, Wang H, Wang Z Exp Ther Med. 2016; 12(3):1585-1590.

PMID: 27602078 PMC: 4998173. DOI: 10.3892/etm.2016.3501.


Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.

Boubaker G, Hemphill A, Huber C, Spiliotis M, Babba H, Gottstein B PLoS Negl Trop Dis. 2015; 9(6):e0003795.

PMID: 26053794 PMC: 4460070. DOI: 10.1371/journal.pntd.0003795.

References
1.
Fu Y, Martinez C, Chalar C, Craig P, Ehrlich R, Petavy A . A new potent antigen from Echinococcus granulosus associated with muscles and tegument. Mol Biochem Parasitol. 1999; 102(1):43-52. DOI: 10.1016/s0166-6851(99)00084-5. View

2.
Nawa Y, Korenaga M . Mast and goblet cell responses in the small intestine of rats concurrently infected with Nippostrongylus brasiliensis and Strongyloides ratti. J Parasitol. 1983; 69(6):1168-70. View

3.
Lamm M . Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol. 1997; 51:311-40. DOI: 10.1146/annurev.micro.51.1.311. View

4.
Tsuji N, Suzuki K, Kasuga-Aoki H, Isobe T, Arakawa T, Matsumoto Y . Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infect Immun. 2003; 71(9):5314-23. PMC: 187325. DOI: 10.1128/IAI.71.9.5314-5323.2003. View

5.
Zhang W, McManus D . Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease?. Trends Parasitol. 2008; 24(9):419-24. DOI: 10.1016/j.pt.2008.05.008. View